Anesthetic Management of Patients Undergoing Percutaneous Endocardial and Epicardial Left Atrial Appendage Occlusion.

摘要: Atrial fibrillation is the most common cardiac arrhythmia in adults affecting almost 6 million United States. The 2 comorbidities associated with atrial are heart failure and thromboembolic events. Heart symptoms may be treated rate control, antiarrhythmic medications or by catheter ablation. Unfortunately, despite optimal medical management, events still occur. Recently, there has been a great deal of interest innovation finding an alternative to chronic anticoagulation. Several percutaneous left appendage occlusion devices have developed over recent years, some which proven noninferior anticoagulation preventing strokes patients. widely used WATCHMAN (Atritech Inc, Plymouth, MN, USA) LARIAT (SentreHEART, Palo Alto, CA, devices. After detailed description procedures, anesthetic considerations each procedure management specific adverse discussed within this review.